[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Commentary
June 2009

Citalopram Treatment in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior

Arch Gen Psychiatry. 2009;66(6):581-582. doi:10.1001/archgenpsychiatry.2009.42

Interest in autism and autism spectrum disorders (ASDs) has increased dramatically over the past decade.1 The convergence of approaches to diagnosis that are based on the DSM-IV and International Statistical Classification of Diseases, 10th Revision, fostered this effort, as did a major and sustained increase in federal funding—stimulated in large part by increasing pressure from parents. This interest has extended to treatment programs as well. For example, the report “Educating Young Children With Autism,” from the National Research Council, summarized the importance of early and sustained intervention for improving long-term outcomes.2,3 A growing body of research has also demonstrated a high rate of comorbid conditions that lead to additional functional impairment.4,5

First Page Preview View Large
First page PDF preview
First page PDF preview
×